Onsdag 17 September | 06:37:36 Europe / Stockholm
Svenska | English

BrainCool

Bifogade filer

Correction: BrainCool AB (publ) - Financial Report for Q1 2024
2024-04-15 19:03:00

There is an error in Business Segment page 5. It is stated that the deliveries of the 350 Systems to ZOLL® will be carried out over 12-18 months. The correct fact is a period over 24 months.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-15 19:03 CEST.

Attachments
Q1 2024 Report Corrected

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden